Evaluation of the peptide nucleic acid fluorescence in situ hybridisation technology for yeast identification directly from positive blood cultures: An Italian experience

Mycoses

Volumn 55, Issue 5, 2012, Pages 388-392

  Farina, Claudio ^a   Perin, Silvana ^a   Andreoni, Stefano ^b   Conte, Marco ^c   Fazii, Paolo ^d   Lombardi, Gianluigi ^e   Manso, Esther ^f   Morazzoni, Cristina ^b   Sanna, Silvana ^g   Bonetti, Cristina ^h   Carretto, Edoardo ⁱ   Casella, Pietro ^j   Luzzaro, Francesco ^k   Marone, Piero ^l   Passera, Marco ^m   Rocchetti, Andrea ^n,o   Vigano, Egidio Franco ^p  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^d SPIRITO SANTO HOSPITAL   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g UNIVERSITY OF SASSARI   (Italy)

^h Medical Mycology Committee   (Italy)

ⁱ AO Ospedale Civile   (Italy)

^j Microbiology Laboratory   (Italy)

^k AO Ospedale Civile   (Italy)

^l A MANZONI HOSPITAL   (Italy)

^m FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁿ OSPEDALI RIUNITI   (Italy)

^o AO Ospedale San Biagio   (Italy)

^p SAN GERARDO HOSPITAL   (Italy)

more..

Author keywords

Blood cultures; Fluorescence in situ hybridisation; Identification; Peptide nucleic acid; Yeast

Indexed keywords

ECHINOCANDIN; PYRROLE DERIVATIVE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DIPODASCUS CAPITATUS; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGAL DETECTION; GRAM STAINING; ITALY; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE NUCLEIC ACID FLUORESCENCE IN SITU HYBRIDIZATION; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; YARROWIA LIPOLYTICA; YEAST;

BLOOD; FUNGEMIA; FUNGI; HOSPITALS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ITALY; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOLOGY; PEPTIDE NUCLEIC ACIDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

CANDIDA;

EID: 84865284675     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02166.x     Document Type: Article

References (30)

1. Martin GS, Mannino DM, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
2. De Pauw BE. Increasing fungal infections in the intensive care unit. Surg Infect (Larchmt) 2006; 7: 93-96.
3. Darouiche RO. Candida in the ICU. Clin Chest Med 2009; 30: 287-93.
4. Ahmad S, Khan Z, Mustafa AS et al. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40: 2483-9.
5. Maaroufi Y, De Bruyne JM, Duchateau V et al. Early detection and identification of commonly encountered Candida species from simulated blood cultures by using a real-time PCR-based assay. J Mol Diagn 2004; 6: 108-14.
6. Innings A, Ullberg M, Johansson A et al. Multiplex real-time PCR targeting the RNAseP RNA gene for detection and identification of Candida species in blood. J Clin Microbiol 2007; 45: 874-80.
7. Metwally L, Hogg G, Coyle PV et al. Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR. J Med Microbiol 2007; 56: 964-70.
8. Dunyach C, Bertout S, Phelipeau C et al. Detection and identification of Candida spp. in human serum by LightCycler real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2008; 60: 263-71.
9. Shin JH, Nolte FS, Holloway BP et al. Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J Clin Microbiol 1999; 37: 165-70.
10. Bassetti M, Trecarichi EM, Righi E et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis 2007; 58: 325-31.
11. Tortorano AM, Dho G, Prigitano A et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses 2011; doi: 10.1111/j.1439-0507.2011.02044.x. [Epub ahead of print]
12. Farina C, Manso E, Andreoni S et al. Interlaboratory evaluation of antifungal susceptibilitry testing. New Microbiol 2011; 34: 157-63.
13. Edmond MB, Wallace SE, McClish DK et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239-44.
14. Leroy O, Gangneux JP, Montravers P et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-8.
15. Shepard JR, Addison RM, Alexander BD et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C.albicans and C.glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46: 50-55.
16. Tortorano AM, Biraghi E, Astolfi A et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 2002; 51: 297-304.
17. Pappas PG, Kauffmann CA, Andès D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
18. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142-51.
19. Tortorano AM, Peman J, Bernhardt H et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-22.
20. Pfaller MA, Castanheira M, Meser SA et al. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Microbiol Infect Dis 2010; 68: 278-83.
21. Morrell M, Fraser VJ, Kollef MJ. Delaying empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for mortality. Antimicrob Agents Chemother 2005; 49: 3640-5.
22. Nguyen MH, Peacock JE Jr, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
23. Cuenca-Estrella M, Rodriguez D, Almirante B et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother 2005; 55: 194-9.
24. Foster N, Symes C, Barton R et al. Rapid identification of Candida glabrata in Candida bloodstream infections. J Med Microbiol 2007; 56: 1639-43.
25. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antimicrobial for Candida infections. EUCAST clinical MIC breakpoints. EUCAST 2008-07-24 (V 2.0).
26. Spiess B, Seifarth W, Hummel M et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007; 45: 3743-53.
27. Marinach-Patrice C, Fekkar A, Atanasova R et al. Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS ONE 2010; 5: e8862.
28. Ferroni A, Suarez S, Beretti JL et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48: 1542-8.
29. Garey KW, Reye M, Pai M et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43: 25-31.
30. Forrest GN, Mankes K, Jabra-Rizk MA et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 2006; 44: 3381-3.